Envoy Medical, Inc. COCH
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -34.62% | -15.22% | 78.57% | -25.00% | 14.71% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -34.62% | -15.22% | 78.57% | -25.00% | 14.71% |
| Cost of Revenue | 18.80% | 38.50% | -86.62% | 8.56% | -4.49% |
| Gross Profit | -45.51% | -52.22% | 146.96% | -22.90% | 11.86% |
| SG&A Expenses | -9.02% | -6.24% | -13.60% | 36.61% | 16.55% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 9.17% | 16.40% | 36.57% | 14.36% | 4.63% |
| Operating Income | -9.84% | -16.68% | -36.18% | -14.80% | -4.49% |
| Income Before Tax | -5.13% | 12.95% | -42.62% | -8.76% | -44.16% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -5.13% | 12.95% | -42.62% | -8.76% | -44.16% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -5.13% | 12.95% | -42.62% | -8.76% | -44.16% |
| EBIT | -9.84% | -16.68% | -36.18% | -14.80% | -4.49% |
| EBITDA | -10.23% | -16.65% | -35.86% | -14.40% | -3.64% |
| EPS Basic | 78.47% | 71.72% | 31.59% | 10.09% | -13.66% |
| Normalized Basic EPS | 78.41% | 73.11% | 5.90% | 7.35% | -25.41% |
| EPS Diluted | 78.47% | 71.72% | 31.59% | 10.09% | -13.66% |
| Normalized Diluted EPS | 78.41% | 73.11% | 5.90% | 7.35% | -25.41% |
| Average Basic Shares Outstanding | 386.53% | 223.23% | 47.17% | 17.38% | 14.97% |
| Average Diluted Shares Outstanding | 386.53% | 223.23% | 47.17% | 17.38% | 14.97% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | 1.00% | -- |